EMILY BELLAMY: Open Payments
NPI 1114678505 · CLINTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 27 payments from 14 companies in 2025. Trend: 2023 $153 · 2024 $292 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $99 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $25 |
| Boston Scientific Corporation | 1 | $24 |
| Insmed, Inc. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Baxter Healthcare | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: LEQVIO, DUPIXENT, Ozempic, WATCHMAN FLX, Arikayce, NEXLETOL, Hillrom - Monarch Airway Clearance System, ILUMYA.
Industry payments across MO — which companies pay providers there.
